CLSN

NASDAQ

Celsion Corporation

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations

News25/Ratings0

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Latest news

25 items

804dSEC
SEC Form S-1/A filed by Celsion Corporation (Amendment)
S-1/A - Imunon, Inc. (0000749647) (Filer)
846dSEC
Celsion Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Imunon, Inc. (0000749647) (Filer)
855dSEC
SEC Form S-1 filed by Celsion Corporation
S-1 - Imunon, Inc. (0000749647) (Filer)
864dINSIDER
Hazard Sebastien was granted 20,000 shares (SEC Form 4)
4 - Imunon, Inc. (0000749647) (Issuer)
864dINSIDER
New insider Hazard Sebastien claimed no ownership of stock in the company (SEC Form 3)
3 - Imunon, Inc. (0000749647) (Issuer)
864dSEC
SEC Form 8-K filed by Celsion Corporation
8-K - Imunon, Inc. (0000749647) (Filer)
986dSEC
SEC Form S-8 filed by Celsion Corporation
S-8 - Imunon, Inc. (0000749647) (Filer)
987dSEC
SEC Form 10-Q filed by Celsion Corporation
10-Q - Imunon, Inc. (0000749647) (Filer)
987dSEC
Celsion Corporation filed SEC Form 8-K: Financial Statements and Exhibits
8-K - Imunon, Inc. (0000749647) (Filer)
1043dSEC
SEC Form 8-K filed by Celsion Corporation
8-K - Imunon, Inc. (0000749647) (Filer)
1044dSEC
Celsion Corporation filed SEC Form 8-K: Leadership Update
8-K - Imunon, Inc. (0000749647) (Filer)
1078dSEC
SEC Form 10-Q filed by Celsion Corporation
10-Q - Imunon, Inc. (0000749647) (Filer)
1078dSEC
Celsion Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Imunon, Inc. (0000749647) (Filer)
1091dSEC
SEC Form DEF 14A filed by Celsion Corporation
DEF 14A - Imunon, Inc. (0000749647) (Filer)
1091dSEC
SEC Form DEFA14A filed by Celsion Corporation
DEFA14A - Imunon, Inc. (0000749647) (Filer)
1120dSEC
SEC Form 10-K filed by Celsion Corporation
10-K - Imunon, Inc. (0000749647) (Filer)
1120dSEC
Celsion Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Imunon, Inc. (0000749647) (Filer)
1126dSEC
Celsion Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Imunon, Inc. (0000749647) (Filer)
1129dINSIDER
SEC Form 4 filed by Braun Donald P
4 - Imunon, Inc. (0000749647) (Issuer)
1129dINSIDER
SEC Form 4 filed by Chow Pok Yu Augustine
4 - Imunon, Inc. (0000749647) (Issuer)
1129dINSIDER
SEC Form 4 filed by Fritz Frederick J.
4 - Imunon, Inc. (0000749647) (Issuer)
1129dINSIDER
SEC Form 4 filed by Pellizzari Christine A
4 - Imunon, Inc. (0000749647) (Issuer)
1129dINSIDER
SEC Form 4 filed by Dentzer James E
4 - Imunon, Inc. (0000749647) (Issuer)
1129dINSIDER
SEC Form 4 filed by Lindborg Stacy
4 - Imunon, Inc. (0000749647) (Issuer)
1129dINSIDER
SEC Form 4 filed by Tardugno Michael H
4 - Imunon, Inc. (0000749647) (Issuer)